Literature DB >> 11803081

A simple selection system for construction of recombinant gD-negative pseudorabies virus as a vaccine vector.

Ai Li Shiau1, Chia Wen Liu, Shiang Yiu Wang, Chiau Yuang Tsai, Chao Liang Wu.   

Abstract

We describe a simple, efficient two-step method for construction of glycoprotein D (gD)-negative pseudorabies virus (PrV) carrying transgenes inserted in place of the gD gene. The first step was the use of the thymidine kinase (TK) gene of herpes simplex virus (HSV) for insertional inactivation of the gD gene in a PrV mutant deficient in both TK and glycoprotein E (gE). The gD-negative, HSV-TK-positive mutant could be selected in HAT medium. The second step was substitution of HSV-TK with other genes of interest. The resultant gD/gE/TK-negative mutant was easily isolated by acyclovir selection. The expression of the transgene was detectable in vivo and the antibody responses against both inserted antigens and PrV were induced. The protective efficacy of the gD/gE/TK-negative PrV against lethal PrV challenge was also demonstrated. This PrV mutant carrying immunogenic proteins from unrelated porcine pathogens may be tested as a multivalent vaccine candidate for swine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11803081     DOI: 10.1016/s0264-410x(01)00426-1

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  Novel strategy for generation and titration of recombinant adeno-associated virus vectors.

Authors:  Ai-Li Shiau; Pu-Ste Liu; Chao-Liang Wu
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  A Thymidine Kinase recombinant protein-based ELISA for detecting antibodies to Duck Plague Virus.

Authors:  Yongping Wen; Anchun Cheng; Mingshu Wang; Han Ge; Chanjuan Shen; Sitong Liu; Jun Xiang; Renyong Jia; Dekang Zhu; Xiaoyue Chen; Bei Lian; Hua Chang; Yi Zhou
Journal:  Virol J       Date:  2010-04-23       Impact factor: 4.099

Review 3.  Targeting the porcine immune system--particulate vaccines in the 21st century.

Authors:  Kenneth C McCullough; Artur Summerfield
Journal:  Dev Comp Immunol       Date:  2008-09-02       Impact factor: 3.636

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.